131 related articles for article (PubMed ID: 7803638)
1. Comparison of three regimens recommended by the Centers for Disease Control and Prevention for the treatment of women hospitalized with acute pelvic inflammatory disease.
Hemsell DL; Little BB; Faro S; Sweet RL; Ledger WJ; Berkeley AS; Eschenbach DA; Wölner-Hanssen P; Pastorek JG
Clin Infect Dis; 1994 Oct; 19(4):720-7. PubMed ID: 7803638
[TBL] [Abstract][Full Text] [Related]
2. A randomized comparison of gentamicin-clindamycin and cefoxitin-doxycycline in the treatment of acute pelvic inflammatory disease.
Walters MD; Gibbs RS
Obstet Gynecol; 1990 May; 75(5):867-72. PubMed ID: 2183112
[TBL] [Abstract][Full Text] [Related]
3. Treatment of hospitalized patients with acute pelvic inflammatory disease: comparison of cefotetan plus doxycycline and cefoxitin plus doxycycline.
Sweet RL; Schachter J; Landers DV; Ohm-Smith M; Robbie MO
Am J Obstet Gynecol; 1988 Mar; 158(3 Pt 2):736-41. PubMed ID: 3162653
[TBL] [Abstract][Full Text] [Related]
4. Comparative evaluation of clindamycin/gentamicin and cefoxitin/doxycycline for treatment of pelvic inflammatory disease: a multi-center trial. The European Study Group.
Acta Obstet Gynecol Scand; 1992 Feb; 71(2):129-34. PubMed ID: 1316041
[TBL] [Abstract][Full Text] [Related]
5. Randomized comparison of ampicillin-sulbactam to cefoxitin and doxycycline or clindamycin and gentamicin in the treatment of pelvic inflammatory disease or endometritis.
McGregor JA; Crombleholme WR; Newton E; Sweet RL; Tuomala R; Gibbs RS
Obstet Gynecol; 1994 Jun; 83(6):998-1004. PubMed ID: 8190448
[TBL] [Abstract][Full Text] [Related]
6. Comparison of cefotetan plus doxycycline with cefoxitin plus doxycycline in the inpatient treatment of acute salpingitis.
Walker CK; Landers DV; Ohm-Smith MJ; Robbie MO; Luft J; Schachter J; Sweet RL
Sex Transm Dis; 1991; 18(2):119-23. PubMed ID: 1862460
[TBL] [Abstract][Full Text] [Related]
7. Comparison of cefotaxime, cefoxitin and clindamycin plus gentamicin in the treatment of uncomplicated and complicated pelvic inflammatory disease.
Martens MG; Faro S; Hammill H; Maccato M; Riddle GD; LaPread E
J Antimicrob Chemother; 1990 Sep; 26 Suppl A():37-43. PubMed ID: 2228843
[TBL] [Abstract][Full Text] [Related]
8. Antibiotic regimens for treating acute pelvic inflammatory disease. An evaluation.
Dodson MG
J Reprod Med; 1994 Apr; 39(4):285-96. PubMed ID: 8040846
[TBL] [Abstract][Full Text] [Related]
9. Comparison of cefoxitin and clindamycin-gentamicin for pelvic infections.
Larsen JW; Voise CT; Grossman JH
Clin Ther; 1986; 9(1):77-83. PubMed ID: 3815461
[TBL] [Abstract][Full Text] [Related]
10. Ciprofloxacin monotherapy for acute pelvic infections: a comparison with clindamycin plus gentamicin.
Thadepalli H; Mathai D; Scotti R; Bansal MB; Savage E
Obstet Gynecol; 1991 Oct; 78(4):696-702. PubMed ID: 1923175
[TBL] [Abstract][Full Text] [Related]
11. Piperacillin and tazobactam versus clindamycin and gentamicin in the treatment of hospitalized women with pelvic infection. The Piperacillin/tazobactam Study Group.
Sweet RL; Roy S; Faro S; O'Brien WF; Sanfilippo JS; Seidlin M
Obstet Gynecol; 1994 Feb; 83(2):280-6. PubMed ID: 8290195
[TBL] [Abstract][Full Text] [Related]
12. Sulbactam/ampicillin in the treatment of acute pelvic inflammatory disease.
Sweet RL; Landers DV; Schachter J; Crombleholme WR
Suppl Int J Gynecol Obstet; 1989; 2():13-9; discussion 47-8. PubMed ID: 2803578
[TBL] [Abstract][Full Text] [Related]
13. [Acute pelvic inflammatory disease: comparison of therapeutic protocols].
Balbi G; Piscitelli V; Di Grazia F; Martini S; Balbi C; Cardone A
Minerva Ginecol; 1996; 48(1-2):19-23. PubMed ID: 8750486
[TBL] [Abstract][Full Text] [Related]
14. Treatment of acute pelvic inflammatory disease in the ambulatory setting: trial of cefoxitin and doxycycline versus ampicillin-sulbactam.
Kosseim M; Ronald A; Plummer FA; D'Costa L; Brunham RC
Antimicrob Agents Chemother; 1991 Aug; 35(8):1651-6. PubMed ID: 1929337
[TBL] [Abstract][Full Text] [Related]
15. Failure of cefoxitin and doxycycline to eradicate endometrial Mycoplasma genitalium and the consequence for clinical cure of pelvic inflammatory disease.
Haggerty CL; Totten PA; Astete SG; Lee S; Hoferka SL; Kelsey SF; Ness RB
Sex Transm Infect; 2008 Oct; 84(5):338-42. PubMed ID: 18445635
[TBL] [Abstract][Full Text] [Related]
16. Identification of novel microbes associated with pelvic inflammatory disease and infertility.
Haggerty CL; Totten PA; Tang G; Astete SG; Ferris MJ; Norori J; Bass DC; Martin DH; Taylor BD; Ness RB
Sex Transm Infect; 2016 Sep; 92(6):441-6. PubMed ID: 26825087
[TBL] [Abstract][Full Text] [Related]
17. Pelvic inflammatory disease.
Peterson HB; Galaid EI; Cates W
Med Clin North Am; 1990 Nov; 74(6):1603-15. PubMed ID: 2246955
[TBL] [Abstract][Full Text] [Related]
18. A multicenter study comparing intravenous meropenem with clindamycin plus gentamicin for the treatment of acute gynecologic and obstetric pelvic infections in hospitalized women.
Hemsell DL; Martens MG; Faro S; Gall S; McGregor JA
Clin Infect Dis; 1997 Feb; 24 Suppl 2():S222-30. PubMed ID: 9126697
[TBL] [Abstract][Full Text] [Related]
19. Multicenter randomized trial of ofloxacin versus cefoxitin and doxycycline in outpatient treatment of pelvic inflammatory disease. Ambulatory PID Research Group.
Martens MG; Gordon S; Yarborough DR; Faro S; Binder D; Berkeley A
South Med J; 1993 Jun; 86(6):604-10. PubMed ID: 8506477
[TBL] [Abstract][Full Text] [Related]
20. Effectiveness of inpatient and outpatient treatment strategies for women with pelvic inflammatory disease: results from the Pelvic Inflammatory Disease Evaluation and Clinical Health (PEACH) Randomized Trial.
Ness RB; Soper DE; Holley RL; Peipert J; Randall H; Sweet RL; Sondheimer SJ; Hendrix SL; Amortegui A; Trucco G; Songer T; Lave JR; Hillier SL; Bass DC; Kelsey SF
Am J Obstet Gynecol; 2002 May; 186(5):929-37. PubMed ID: 12015517
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
